T-knife Therapeutics’ $110 Million Series B Financing

Fenwick & West advised T-knife Therapeutics on the deal. Torys LLP acted as counsel to Sixty Degree Capital. T-knife Therapeutics, Inc., a next-generation T-cell receptor company…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now